Updates in Limb-Girdle Muscular Dystrophy (LGMD)

Release Date: May 7, 2024

End Date: May 7, 2025

Activity Overview

This webinar will explore updates in limb-girdle muscular dystrophy (LGMD). Topics will include an overview of LGMD disease subtypes and clinical management, new nomenclature for LGMD, and current and emerging treatments.

Target Audience

This activity is designed for an audience of nurses, nurse practitioners, pharmacists, physicians, physician associates.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Criteria for Success 

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate.  You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected]. 

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 1 ANCC contact hours

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1 contact hour.

Physician Associate

Nurse Practitioners

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MDA.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1 contact hour(s) (which includes 0 hour(s) of pharmacology).

Social Workers

As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 1 continuing education credits.

Commercial Support

There is no commercial support for this activity.

Disclosures

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

DISCLOSURES
Name	Relationship	Commercial Interest
Chamindra G. Laverty MD	Consultant	Sarepta Therapeutics, Avidity Biosciences, Catalyst, Novartis, Biogen
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer)	N/A	Nothing to disclose
Dorothy Duffy, RPh (planner/reviewer)	N/A	Nothing to disclose
Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer)	N/A	Nothing to disclose
AKH Inc Staff and Planners	N/A	Nothing to disclose
MDA Staff and Planners	N/A	Nothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.